PITX3 Gene (Cataract 11, Multiple Types) Genetic Test in UAE | 2,800 AED | DNA Labs UAE

Executive Summary & Core Metrics

Diagnostic sensitivity exceeding 99.9% through ISO-accredited processing at our licensed laboratory.
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Post-test telephone consultation to guide clinical interpretation of results.
Direct insurance verification and invoice delivery via WhatsApp: +971 54 548 8731.

Test Overview & Methodology

Comprehensive PITX3 Gene Analysis for Congenital Cataract – Precision, Speed, and UAE Compliance

This test screens the entire coding region of the PITX3 gene using Next Generation Sequencing (NGS) to detect pathogenic variants associated with Cataract 11 (multiple types) – a leading cause of congenital anterior segment dysgenesis. Full gene coverage ensures detection of single nucleotide variants, small insertions and deletions, and copy number alterations.

Feature	Our Test	Closest Alternative (Sanger Sequencing)
Method	Next Generation Sequencing (NGS) – Full gene coverage	Single‑exon targeted Sanger sequencing
Analytical Sensitivity	>99.9% (SNVs/indels, CNV analysis optional)	~98% for small variants, poor for large rearrangements
Turnaround Time	3–4 weeks	6–8 weeks (if multiple exons tested separately)
Clinical Utility	Comprehensive variant detection, research-grade data	Limited to known familial mutation; risk of missing novel variants

Physician Insight & Safety Protocols

“Genetic testing is a powerful adjunct to the ophthalmic examination. Never rely solely on a DNA result – clinical correlation with slit‑lamp biomicroscopy is essential, and all management decisions must be taken with your treating ophthalmologist. Do not discontinue prescribed medication without consulting your doctor.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Patient Safety & Exclusion Criteria

Acute ocular infection or recent eye trauma: Postpone sample collection until resolution; this test is not suited for emergency diagnosis.
Minors (individuals under 18 years): A legal guardian must provide informed written consent in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Emergency Red Flags: If the patient experiences sudden vision loss, severe eye pain, acute redness, or photophobia, seek immediate emergency ophthalmologic care. This test does not replace urgent clinical evaluation.
Pre‑Test Genetic Counselling (Mandatory): A pedigree chart documenting family members affected by PITX3‑related cataract must be drawn during a genetic counselling session prior to sample collection. Provide complete clinical history of the patient.

Patient FAQ & Clinical Guidance

1. What does the PITX3 gene test detect and who should consider it?

This NGS test identifies pathogenic mutations in PITX3, confirming congenital cataract subtypes and guiding early surgical or genetic counselling interventions. It is recommended for infants or children with congenital anterior segment anomalies, adults with early‑onset cataract, and family members planning reproductive genetic screening. A pre‑test genetic counselling session is required to evaluate inheritance patterns (autosomal dominant) and to map affected relatives.

2. Why choose NGS over single‑gene Sanger testing for PITX3?

NGS provides 99.9% analytical sensitivity across the entire PITX3 gene, detecting point mutations, small insertions/deletions, and copy number variants missed by targeted Sanger assays. This approach reduces the risk of false‑negative results and eliminates the need for sequential single‑exon testing, saving time and providing a complete genetic profile that can inform prognosis and family screening.

3. How do I prepare for the test and what sample is needed?

Attend the mandatory genetic counselling session with family medical history; samples accepted are whole blood, extracted DNA, or a single‑drop FTA card. Our VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection service operates daily from 8 AM to 11 PM. No fasting or medication changes are required, but you must continue all prescribed therapy unless your doctor advises otherwise. Contact us on WhatsApp (+971 54 548 8731) to schedule collection and verify insurance pre‑authorization.

UAE Regulatory & Data Privacy Adherence

This service fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical safety protocols and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic data is handled under strict confidentiality controls with encrypted storage and access limited to authorised medical personnel.

Clinical & Logistical Metadata

Test Name	PITX3 Gene (Cataract 11, Multiple Types) Genetic Test
Price (AED)	2,800
Turnaround Time	3–4 weeks
Sample Type / Matrix	Whole Blood, Extracted DNA, or FTA Card
Methodology Used	Next Generation Sequencing (NGS) – Full Gene Coverage
ICD-10-CM Code	Q12.0
LOINC Code	94832-4
DHA Facility License & Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE